Vinorelbine Delivery and Efficacy in the MDA-MB-231BR Preclinical Model of Brain Metastases of Breast Cancer | Zendy

Ramakrishna Samala | Zendy; Helen R. Thorsheim | Zendy; Satyanarayana Goda | Zendy; Kunal S. Taskar | Zendy; Brunilde Gril | Zendy; Patricia S. Steeg | Zendy; Quentin R. Smith | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Vinorelbine Delivery and Efficacy in the MDA-MB-231BR Preclinical Model of Brain Metastases of Breast Cancer

Author(s) -

Ramakrishna Samala,

Helen R. Thorsheim,

Satyanarayana Goda,

Kunal S. Taskar,

Brunilde Gril,

Patricia S. Steeg,

Quentin R. Smith

Publication year - 2016

Publication title -

pharmaceutical research

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.815

H-Index - 206

eISSN - 1573-904X

pISSN - 0724-8741

DOI - 10.1007/s11095-016-2012-3

Subject(s) - vinorelbine , brain metastasis , medicine , in vivo , metastasis , breast cancer , systemic administration , cancer , brain tumor , pathology , blood–brain barrier , evans blue , biomarker , pharmacology , chemotherapy , central nervous system , chemistry , biology , biochemistry , microbiology and biotechnology , cisplatin

To evaluate vinorelbine drug exposure and activity in brain metastases of the human MDA-MB-231BR breast cancer model using integrated imaging and analysis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research